Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations

Abstract Bacterial and fungal infections are common issues for patients in the intensive care unit (ICU). Large, multinational point prevalence surveys have identified that up to 50% of ICU patients have a diagnosis of bacterial or fungal infection at any one time. Infection in the ICU is associated with its own challenges. Causative organisms often harbour intrinsic and acquired mechanisms of drug-resistance, making empiric and targeted antimicrobial selection challenging. Infection in the ICU is associated with worse clinical outcomes for patients. We review the epidemiology of bacterial and fungal infection in the ICU. We discuss risk factors for acquisition, approaches to diagnosis and management, and common strategies for the prevention of infection.

[1]  T. Rawson,et al.  Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design , 2023, Clinical Microbiology and Infection.

[2]  K. Klouche,et al.  Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial , 2023, Clinical Microbiology and Infection.

[3]  G. Guyatt,et al.  Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis. , 2022, JAMA.

[4]  A. Gordon,et al.  Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. , 2022, JAMA.

[5]  M. Girardis,et al.  Source control in the management of sepsis and septic shock , 2022, Intensive Care Medicine.

[6]  D. Seidel,et al.  COVID-19-associated fungal infections , 2022, Nature Microbiology.

[7]  A. Christensen,et al.  Impact of a Laboratory-Developed Phenotypic Rapid Susceptibility Test Directly From Positive Blood Cultures on Time to Narrowest Effective Therapy in Patients With Gram-Negative Bacteremia: A Prospective Randomized Trial , 2022, Open forum infectious diseases.

[8]  M. Boermeester,et al.  Perioperative care bundles for the prevention of surgical-site infections: meta-analysis , 2022, The British journal of surgery.

[9]  M. Rupp,et al.  Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update , 2022, Infection Control & Hospital Epidemiology.

[10]  B. Zwaan,et al.  Tackling the emerging threat of antifungal resistance to human health , 2022, Nature reviews. Microbiology.

[11]  A. Oliver,et al.  Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain. , 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  D. Pittet,et al.  Impact of environmental hygiene interventions on healthcare-associated infections and patient colonization: a systematic review , 2022, Antimicrobial resistance and infection control.

[13]  P. Schlattmann,et al.  Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial , 2022, Intensive Care Medicine.

[14]  F. Youssef,et al.  802. Corynebacterium striatum Outbreak Among Ventilated COVID-19 Patients in an Acute Care Hospital – California, 2021 , 2021, Open Forum Infectious Diseases.

[15]  M. Kollef,et al.  Timing of antibiotic therapy in the ICU , 2021, Critical Care.

[16]  C. Sprung,et al.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.

[17]  Joseph M. Galante,et al.  WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections , 2021, World Journal of Emergency Surgery.

[18]  Philip R. O. Payne,et al.  Comparison of early warning scores for sepsis early identification and prediction in the general ward setting , 2021, JAMIA open.

[19]  P. Georgiou,et al.  Optimizing antimicrobial use: challenges, advances and opportunities , 2021, Nature Reviews Microbiology.

[20]  A. Irwin,et al.  New Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Including Point of Care , 2021, Current Infectious Disease Reports.

[21]  M. Hoenigl,et al.  Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches , 2021, Mycoses.

[22]  P. Woo,et al.  Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. , 2021, The Lancet. Infectious diseases.

[23]  H. Sakata,et al.  The JAID/JSC guidelines for management of infectious diseases 2017 - Sepsis and catheter-related bloodstream infection. , 2021, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[24]  Karsten M. Borgwardt,et al.  Early Prediction of Sepsis in the ICU Using Machine Learning: A Systematic Review , 2020, Frontiers in Medicine.

[25]  E. Balman,et al.  National Institute for Health and Care Excellence (NICE) , 2017, The Grants Register 2022.

[26]  OUP accepted manuscript , 2021, Journal of Antimicrobial Chemotherapy.

[27]  J. Timsit,et al.  Molecular diagnostic methods for pneumonia: how can they be applied in practice? , 2020, Current opinion in infectious diseases.

[28]  J. Perfect,et al.  Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance , 2020, The Lancet Infectious Diseases.

[29]  A. Holmes,et al.  Understanding the role of bacterial and fungal infection in COVID-19 , 2020, Clinical Microbiology and Infection.

[30]  O. Pajot,et al.  Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU , 2020, Annals of Intensive Care.

[31]  Anita Løvås Brekken,et al.  EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories , 2020, The Journal of antimicrobial chemotherapy.

[32]  O. Laitinen,et al.  Modern Tools for Rapid Diagnostics of Antimicrobial Resistance , 2020, Frontiers in Cellular and Infection Microbiology.

[33]  Kailiang Xu,et al.  Risk Factors of Multidrug-Resistant Bacteria in Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis , 2020, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[34]  Russell E. Lewis,et al.  Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion , 2020, Intensive Care Medicine.

[35]  A. Holmes,et al.  Antimicrobial use, drug-resistant infections and COVID-19 , 2020, Nature Reviews Microbiology.

[36]  A. Gayet-Ageron,et al.  Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. , 2020, JAMA.

[37]  F. Davies,et al.  COVID-19 and the potential long-term impact on antimicrobial resistance , 2020, The Journal of antimicrobial chemotherapy.

[38]  M. Holubar,et al.  Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study , 2020, Journal of Clinical Microbiology.

[39]  D. Marriott,et al.  Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# , 2020, Intensive Care Medicine.

[40]  Fang Zhang,et al.  Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use , 2020, JAMA network open.

[41]  Y. Mehta,et al.  Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. , 2020, JAMA.

[42]  A. Christe,et al.  Risk factors for candidemia: a prospective matched case-control study , 2020, Critical Care.

[43]  Philip Smith,et al.  Fluconazole‐resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa , 2020, Mycoses.

[44]  B. Milošević,et al.  Hospital-acquired infections in the adult intensive care unit-Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality. , 2020, American journal of infection control.

[45]  A. van Belkum,et al.  Innovative and rapid antimicrobial susceptibility testing systems , 2020, Nature Reviews Microbiology.

[46]  J. Berman,et al.  Drug resistance and tolerance in fungi , 2020, Nature Reviews Microbiology.

[47]  G. Kahlmeter,et al.  The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles , 2020, The Journal of antimicrobial chemotherapy.

[48]  J. Timsit,et al.  Bloodstream infections in critically ill patients: an expert statement , 2020, Intensive Care Medicine.

[49]  D. Gould,et al.  Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England , 2020, BMJ Open.

[50]  W. Meyer,et al.  A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready? , 2020, Frontiers in Microbiology.

[51]  M. Singer,et al.  Sepsis hysteria: excess hype and unrealistic expectations , 2019, The Lancet.

[52]  P. White,et al.  Pneumocystis jirovecii Pneumonia: Epidemiology, Clinical Manifestation and Diagnosis , 2019, Current Fungal Infection Reports.

[53]  M. Ghannoum,et al.  Resistance of Candida to azoles and echinocandins worldwide. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[54]  B. Cao,et al.  Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition). , 2019, Journal of thoracic disease.

[55]  J. Powers,et al.  Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis. , 2019, Chest.

[56]  Y. Zhong,et al.  Risk Factors of Ventilator-Associated Pneumonia in Critically III Patients , 2019, Front. Pharmacol..

[57]  Seungkyung Park,et al.  Current and Emerging Methods of Antibiotic Susceptibility Testing , 2019, Diagnostics.

[58]  P. Mathur,et al.  Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India , 2019, The Journal of antimicrobial chemotherapy.

[59]  N. Damani Surveillance and outbreak management , 2019, Manual of Infection Prevention and Control.

[60]  B. Wickes,et al.  Molecular diagnostics in medical mycology , 2018, Nature Communications.

[61]  M. Boermeester,et al.  2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections , 2018, World Journal of Emergency Surgery.

[62]  W. Dunne,et al.  Developmental roadmap for antimicrobial susceptibility testing systems , 2018, Nature Reviews Microbiology.

[63]  S. Lockhart,et al.  Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. , 2018, The Lancet. Infectious diseases.

[64]  A. Walker,et al.  A Candida auris Outbreak and Its Control in an Intensive Care Setting , 2018, The New England journal of medicine.

[65]  G. Maartens,et al.  Erratum to South African guideline for the management of community-acquired pneumonia in adults. , 2018, Journal of thoracic disease.

[66]  P. Georgiou,et al.  Exploring the Use of C-Reactive Protein to Estimate the Pharmacodynamics of Vancomycin , 2018, Therapeutic drug monitoring.

[67]  B. Kullberg,et al.  Invasive Candidiasis. , 2019, The New England journal of medicine.

[68]  C. Clancy,et al.  Diagnosing Invasive Candidiasis , 2018, Journal of Clinical Microbiology.

[69]  M. Poljak,et al.  Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance , 2018, Intensive Care Medicine.

[70]  T. A. Gray,et al.  The effects of care bundles on patient outcomes: a systematic review and meta-analysis , 2017, Implementation Science.

[71]  R. Trevethan,et al.  Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice , 2017, Front. Public Health.

[72]  R. Wunderink,et al.  International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia , 2017, European Respiratory Journal.

[73]  David Baur,et al.  Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. , 2017, The Lancet. Infectious diseases.

[74]  S. Marsch,et al.  Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[75]  M. Rosengart,et al.  The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection. , 2017, Surgical infections.

[76]  E. Mylonakis,et al.  The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[77]  M. Egger,et al.  Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations , 2017, Antimicrobial Resistance & Infection Control.

[78]  Sarah K. Parker,et al.  Implementation of Rapid Molecular Infectious Disease Diagnostics: the Role of Diagnostic and Antimicrobial Stewardship , 2016, Journal of Clinical Microbiology.

[79]  Pantelis Georgiou,et al.  Mapping the decision pathways of acute infection management in secondary care among UK medical physicians: a qualitative study , 2016, BMC Medicine.

[80]  C. Thomson,et al.  Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia. , 2016, Annals of the American Thoracic Society.

[81]  M. Neely,et al.  Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy. , 2016, The Journal of antimicrobial chemotherapy.

[82]  Matthew Fisher,et al.  First hospital outbreak of the globally emerging Candida auris in a European hospital , 2016, Antimicrobial Resistance & Infection Control.

[83]  M. Siegemund,et al.  Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. , 2016, Swiss medical weekly.

[84]  R. Bellomo,et al.  Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials. , 2016, American journal of respiratory and critical care medicine.

[85]  L. Lagunes,et al.  Current understanding in source control management in septic shock patients: a review. , 2016, Annals of translational medicine.

[86]  R. Moraes,et al.  De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: an observational study , 2016, Revista Brasileira de terapia intensiva.

[87]  Peggy Cruse,et al.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[88]  A. Cheng,et al.  Risk factors associated with urinary tract infections in intensive care patients , 2016 .

[89]  Pierre Tattevin,et al.  How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art , 2016, Front. Microbiol..

[90]  P. Wilson,et al.  The Intensive Care Society recommended bundle of interventions for the prevention of ventilator-associated pneumonia , 2016, Journal of the Intensive Care Society.

[91]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[92]  A. Holmes,et al.  Plasmid-mediated colistin resistance mechanisms: is it time to revise our approach to selective digestive decontamination? , 2016, The Lancet. Infectious diseases.

[93]  M. Neely,et al.  Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy , 2016, Antimicrobial Agents and Chemotherapy.

[94]  M. Arendrup,et al.  Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study , 2015, Antimicrobial Agents and Chemotherapy.

[95]  Robin Patel,et al.  Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[96]  T. Welte,et al.  Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria , 2015, Intensive Care Medicine.

[97]  B. Kullberg,et al.  Invasive Candidiasis. , 2015, The New England journal of medicine.

[98]  Blake W Buchan,et al.  Emerging Technologies for the Clinical Microbiology Laboratory , 2014, Clinical Microbiology Reviews.

[99]  S. Saint,et al.  Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals: 2014 Update , 2014, Infection Control & Hospital Epidemiology.

[100]  E. P. Dellinger,et al.  Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[101]  Jan V Hirschmann,et al.  Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[102]  Y. Carmeli,et al.  Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. , 2014, The Journal of antimicrobial chemotherapy.

[103]  S. Saint,et al.  Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals: 2014 Update , 2014, Infection Control & Hospital Epidemiology.

[104]  J. Rello,et al.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[105]  R. Lynfield,et al.  Multistate point-prevalence survey of health care-associated infections. , 2014, The New England journal of medicine.

[106]  S. Saint,et al.  Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review , 2013, BMJ quality & safety.

[107]  Nagler Test UK Standards for Microbiology Investigations , 2014 .

[108]  M. Montagna,et al.  Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project) , 2013, Infection.

[109]  Howard S. Kim Daily Sedation Interruption in Mechanically Ventilated Critically Ill Patients Cared for with a Sedation Protocol , 2013 .

[110]  Liang-yu Chen,et al.  A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study , 2013, BMC Infectious Diseases.

[111]  Geoff Bellingan,et al.  ‘Matching Michigan’: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England , 2012, BMJ quality & safety.

[112]  Sangeeta Mehta,et al.  Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. , 2012, JAMA.

[113]  L. Leibovici,et al.  Diagnostic Accuracy of PCR Alone Compared to Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis: a Systematic Review , 2012, Journal of Clinical Microbiology.

[114]  Gilbert GREUB,et al.  Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. , 2012, FEMS microbiology reviews.

[115]  B. Spellberg,et al.  Pathogenesis of mucormycosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[116]  G. Bloemberg,et al.  Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[117]  F. V. van Tiel,et al.  Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009 , 2011, Emerging infectious diseases.

[118]  K. Ho,et al.  Meta-Analysis of Randomised Controlled Trials on Daily Sedation Interruption for Critically Ill Adult Patients , 2011, Anaesthesia and intensive care.

[119]  Matthew Samore,et al.  Intervention to reduce transmission of resistant bacteria in intensive care. , 2011, The New England journal of medicine.

[120]  M. Falagas,et al.  β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[121]  J. Marshall,et al.  Principles of source control in the management of sepsis. , 2011, Critical care nursing clinics of North America.

[122]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[123]  T. Calandra,et al.  The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia , 2010, Critical care.

[124]  S. Tschudin-Sutter,et al.  Hand hygiene in the intensive care unit. , 2010, Critical care medicine.

[125]  Jordi Rello,et al.  A European care bundle for prevention of ventilator-associated pneumonia , 2010, Intensive Care Medicine.

[126]  E. P. Dellinger,et al.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[127]  Á. Atallah,et al.  De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. , 2010, The Cochrane database of systematic reviews.

[128]  Richard Beale,et al.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis , 2010, Intensive Care Medicine.

[129]  E. Tacconelli,et al.  Screening and isolation for infection control. , 2009, The Journal of hospital infection.

[130]  J. Marshall,et al.  Principles of source control in the management of sepsis. , 2009, Critical care clinics.

[131]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[132]  Jay Steingrub,et al.  International study of the prevalence and outcomes of infection in intensive care units , 2009 .

[133]  M. Kristjansson,et al.  Risk factors and outcome in ICU‐acquired infections , 2008, Acta anaesthesiologica Scandinavica.

[134]  S. Saint,et al.  Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.

[135]  Carlene A. Muto,et al.  Measures to control and prevent Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[136]  G. Bernard,et al.  Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial , 2008, The Lancet.

[137]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[138]  Patchen Dellinger,et al.  Practice guidelines for the diagnosis and management of skin and soft-tissue infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[139]  France Gauvin,et al.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[140]  Marin H Kollef,et al.  Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[141]  S. Hugonnet,et al.  Effectiveness of a hospital-wide programme to improve compliance with hand hygiene , 2000, The Lancet.

[142]  W. Stamm Guidelines for prevention of catheter-associated urinary tract infections. , 1975, Annals of internal medicine.